Company Filing History:
3 out of 656 
2 out of 212 
1 out of 28 Years Active: 1989-2000
Title: Arthur D Newell: Innovator in Vaccine Adjuvants
Introduction
Arthur D Newell is a notable inventor based in Orinda, CA (US). He has made significant contributions to the field of immunology, particularly in the development of vaccine adjuvants. With a total of 6 patents to his name, Newell's work has had a profound impact on enhancing immune responses in both animals and humans.
Latest Patents
One of Newell's latest patents focuses on the use of human interleukin-2 (IL-2) as a vaccine adjuvant. This innovative method enhances the immune response to vaccination by administering IL-2 as part of the vaccination regimen, preferably for 5 to 14 days post-vaccination. The compositions developed for this purpose employ IL-2 as an active ingredient, specifically human IL-2, to improve the efficacy of vaccines.
Career Highlights
Throughout his career, Arthur D Newell has worked with prominent companies in the biotechnology sector, including Chiron Corporation and Cetus Corporation. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of Newell's notable coworkers include Michael V Doyle and Jack H Nunberg. Their collaborative efforts have further advanced the research and development of vaccine technologies.
Conclusion
Arthur D Newell's innovative work in vaccine adjuvants exemplifies the importance of research in enhancing immune responses. His contributions continue to influence the field of immunology and pave the way for future advancements in vaccination strategies.